vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
19.67
-0.03 (-0.15%)
Apr 21, 2025, 4:00 PM EDT - Market closed
vTv Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for vTv Therapeutics stock have an average target of 35.5, with a low estimate of 35 and a high estimate of 36. The average target predicts an increase of 80.48% from the current stock price of 19.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for vTv Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Buy | 1 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +83.02% | Apr 9, 2025 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +77.94% | Dec 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +1,120.13% | Mar 7, 2023 |
Northland Capital Markets | Northland Capital Markets | Buy Maintains $60 → $80 | Buy | Maintains | $60 → $80 | +306.71% | Aug 17, 2022 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $200 | Buy | Initiates | $200 | +916.78% | Feb 18, 2022 |
Financial Forecast
Revenue This Year
n/a
from 1.02M
Revenue Next Year
n/a
EPS This Year
-4.23
from -3.20
EPS Next Year
-4.64
from -4.23
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -4.36 | -4.78 | -4.99 | ||
Avg | -4.23 | -4.64 | -4.85 | ||
Low | -4.07 | -4.46 | -4.66 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.